Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Charmacy Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	53.28	51.34	90.47	23.15
Depreciation & Amortization	29.75	26.47	30.68	32.03
Other Amortization	6.27	2.95	2.89	1.73
Loss (Gain) From Sale of Assets	-0.31	-0.05	-65.84	-0.15
Asset Writedown & Restructuring Costs	0.36	-0.01	-	0.01
Loss (Gain) From Sale of Investments	-	0.1	-	-0
Provision & Write-off of Bad Debts	0.07	0.8	2.48	-0.29
Other Operating Activities	38.14	41.16	36.31	41.71
Change in Accounts Receivable	-409.63	-98.17	-222.47	-54.81
Change in Inventory	116.04	-193.35	-77.74	75.75
Change in Accounts Payable	272.54	72.25	245.77	-139.9
Operating Cash Flow	106.04	-96.54	44.05	-19.54
Capital Expenditures	-15.73	-40.85	-8.59	-25.04
Sale of Property, Plant & Equipment	0.08	80.19	80.35	0.64
Other Investing Activities	-	-	-	0
Investing Cash Flow	-15.64	39.34	71.76	-24.4
Short-Term Debt Issued	3,688	2,492	2,852	1,807
Long-Term Debt Issued	1,266	836.6	2.26	974.03
Total Debt Issued	4,955	3,329	2,855	2,781
Short-Term Debt Repaid	-3,883	-2,388	-3,017	-1,830
Long-Term Debt Repaid	-1,038	-767.41	-3.58	-824.11
Total Debt Repaid	-4,921	-3,156	-3,021	-2,654
Net Debt Issued (Repaid)	33.98	172.72	-166.48	126.33
Common Dividends Paid	-64.2	-75.5	-28.44	-52.49
Other Financing Activities	-1.31	4.04	3.71	0.56
Financing Cash Flow	-31.54	101.26	-191.21	74.4
Foreign Exchange Rate Adjustments	0.01	0.01	0.03	-
Net Cash Flow	58.87	44.07	-75.37	30.46
Free Cash Flow	90.31	-137.39	35.46	-44.58
Free Cash Flow Margin	2.04%	-3.12%	0.85%	-1.18%
Free Cash Flow Per Share	0.84	-1.27	0.33	-0.41
Cash Income Tax Paid	52.98	58.86	36.02	37.42
Levered Free Cash Flow	-69.75	10.27	-145.91	-28.06
Unlevered Free Cash Flow	-30.71	36.48	-123.99	-2.12
Change in Working Capital	-21.53	-219.31	-52.94	-117.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.